Drug recall · November 27, 2019
Valganciclovir Hydrochloride for Oral Solution recall
Why: Presence of foreign substance: Brown/black particles found during stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, 100 mL (3.4 fl. oz.) bottle, Rx only, Manufactured for: Actavis Laboratories FL. Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-2579-20
- Lots / codes
Lot #: CBFCN, CBHFG, Exp 05/2020
- Quantity
- 3,623 bottles
- Company
- Teva Pharmaceuticals USA, Inc., North Wales, PA
- Distribution
- Product was distributed to wholesalers/distributors throughout the United States.
- Initiated
- November 4, 2019 · Voluntary: Firm initiated
- Classified
- November 21, 2019
- Reported
- November 27, 2019
- Ended
- November 17, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Valganciclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.